{"authors": ["Ted Alcorn"], "date_download": "2022-10-25 23:52:08", "date_modify": "2022-10-25 23:52:08", "date_publish": "2018-03-15 09:00:10", "description": "Since this insidious disease became curable, judges have begun ordering prisons to pay the high cost of treatment, setting up a showdown over drug pricing.", "filename": "2018_03_15_us_hepatitis-c-drugs-prisons_1666741928.html", "image_url": "https://static01.nyt.com/images/2018/03/17/us/17hepatitis-01/00hepatitis-01-facebookJumbo.jpg?year=2018&h=550&w=1050&s=5e69f00ade946bf13faaaed66f0328688cab555c798ceb91950ca8e30012bb0d&k=ZQJBKqZ0VN", "language": "en", "localpath": "/Users/matthewwhite/news-please-repo//data/2022/10/25/nytimes.com/2018_03_15_us_hepatitis-c-drugs-prisons_1666741928.html", "title": "Hepatitis C Drugs Save Lives, but Sick Prisoners Aren’t Getting Them", "title_page": "Hepatitis C Drugs Save Lives, but Sick Prisoners Aren’t Getting Them - The New York Times", "title_rss": "NULL", "source_domain": "nytimes.com", "maintext": "Any national campaign to eliminate hepatitis C, an insidious virus that kills tens of thousands of Americans a year, would almost certainly involve prisons.\nOne in seven state inmates are believed to be infected, and the regimented environment of a prison has its advantages when it comes to screening and treatment.\nThe problem is, the drugs that effectively cure the disease are priced in the tens of thousands of dollars — far more than prisons can pay. In 2015, state corrections departments were treating less than 1 percent of those inmates known to be infected, a survey found.\nNow courts have begun ordering states to provide the drugs regardless of cost, prompting an unusual showdown over how pharmaceutical companies set prices for the treatments.", "url": "https://www.nytimes.com/2018/03/15/us/hepatitis-c-drugs-prisons.html"}